Identification of an optimal dose of intravenous ketamine for late-life treatment-resistant depression: a Bayesian adaptive randomization trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of an optimal dose of intravenous ketamine for late-life treatment-resistant depression: a Bayesian adaptive randomization trial
Authors
Keywords
-
Journal
NEUROPSYCHOPHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-11-27
DOI
10.1038/s41386-021-01242-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety, Tolerability, and Real-World Effectiveness of Intravenous Ketamine in Older Adults With Treatment-Resistant Depression: A Case Series
- (2021) Orly Lipsitz et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Evaluating Bayesian adaptive randomization procedures with adaptive clip methods for multi-arm trials
- (2021) Kim May Lee et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Does mismatch negativity have utility for NMDA receptor drug development in depression?
- (2021) Nicholas Murphy et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Neurophysiological and clinical effects of the NMDA receptor antagonist lanicemine (BHV‐5500) in PTSD: A randomized, double‐blind, placebo‐controlled trial
- (2021) Nithya Ramakrishnan et al. DEPRESSION AND ANXIETY
- Fine-tuning neural excitation/inhibition for tailored ketamine use in treatment-resistant depression
- (2021) Erik D. Fagerholm et al. Translational Psychiatry
- Electrophysiological biomarkers of antidepressant response to ketamine in treatment-resistant depression: Gamma power and long-term potentiation
- (2020) Jessica R. Gilbert et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Rapastinel, an NMDAR Positive Modulator, Produces Distinct Behavioral, Sleep, and EEG Profiles Compared with Ketamine
- (2020) Pradeep Banerjee et al. BEHAVIOURAL BRAIN RESEARCH
- Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression
- (2020) Cristan A. Farmer et al. NEUROPSYCHOPHARMACOLOGY
- EEG alpha reactivity and cholinergic system integrity in Lewy body dementia and Alzheimer’s disease
- (2020) Julia Schumacher et al. Alzheimers Research & Therapy
- A randomized cross-over trial to define neurophysiological correlates of AV-101 N-methyl-d-aspartate receptor blockade in healthy veterans
- (2020) Nicholas Murphy et al. NEUROPSYCHOPHARMACOLOGY
- Cortical GABAergic Dysfunction in Stress and Depression: New Insights for Therapeutic Interventions
- (2019) Manoela V. Fogaça et al. Frontiers in Cellular Neuroscience
- Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression—TRANSFORM-3
- (2019) Rachel Ochs-Ross et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects
- (2018) Allison C. Nugent et al. MOLECULAR PSYCHIATRY
- Reduced GABAergic cortical inhibition in aging and depression
- (2018) Jennifer I. Lissemore et al. NEUROPSYCHOPHARMACOLOGY
- The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects
- (2018) Chadi G. Abdallah et al. NEUROPSYCHOPHARMACOLOGY
- The neurobiology of depression, ketamine and rapid-acting antidepressants: Is it glutamate inhibition or activation?
- (2018) Chadi G. Abdallah et al. PHARMACOLOGY & THERAPEUTICS
- On the Physiological Modulation and Potential Mechanisms Underlying Parieto-Occipital Alpha Oscillations
- (2018) Diego Lozano-Soldevilla Frontiers in Computational Neuroscience
- Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
- (2018) Maurizio Fava et al. MOLECULAR PSYCHIATRY
- The Nucleus Accumbens and Ketamine Treatment in Major Depressive Disorder
- (2017) Chadi G Abdallah et al. NEUROPSYCHOPHARMACOLOGY
- Spontaneous Neural Oscillations Bias Perception by Modulating Baseline Excitability
- (2016) Luca Iemi et al. JOURNAL OF NEUROSCIENCE
- Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories
- (2016) T. Kishimoto et al. PSYCHOLOGICAL MEDICINE
- Failed Response to Repeat Intravenous Ketamine Infusions in Geriatric Patients With Major Depressive Disorder
- (2014) Sarah M. Szymkowicz et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Prestimulus Neural Oscillations Inhibit Visual Perception via Modulation of Response Gain
- (2014) Maximilien Chaumon et al. JOURNAL OF COGNITIVE NEUROSCIENCE
- Reverse Translation of Clinical Electrophysiological Biomarkers in Behaving Rodents under Acute and Chronic NMDA Receptor Antagonism
- (2014) Elyse M Sullivan et al. NEUROPSYCHOPHARMACOLOGY
- Age-Related Changes in Antidepressant Pharmacokinetics and Potential Drug-Drug Interactions: A Comparison of Evidence-Based Literature and Package Insert Information
- (2012) Richard D. Boyce et al. American Journal Geriatric Pharmacotherapy
- Mechanisms of Gamma Oscillations
- (2012) György Buzsáki et al. Annual Review of Neuroscience
- The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults
- (2011) Kelly Posner et al. AMERICAN JOURNAL OF PSYCHIATRY
- Differential Role of NR2A and NR2B Subunits in N-Methyl-D-Aspartate Receptor Antagonist-Induced Aberrant Cortical Gamma Oscillations
- (2011) Bernat Kocsis BIOLOGICAL PSYCHIATRY
- Efficacy of Antidepressants for Late-Life Depression
- (2011) Enrico Tedeschini et al. JOURNAL OF CLINICAL PSYCHIATRY
- NMDA Receptor Ablation on Parvalbumin-Positive Interneurons Impairs Hippocampal Synchrony, Spatial Representations, and Working Memory
- (2010) Tatiana Korotkova et al. NEURON
- RESEARCH: Validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ)
- (2009) Gregory M. Chandler et al. CNS Neuroscience & Therapeutics
- Efficacy of Second Generation Antidepressants in Late-Life Depression: A Meta-Analysis of the Evidence
- (2008) J Craig Nelson et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Population projection of US adults with lifetime experience of depressive disorder by age and sex from year 2005 to 2050
- (2008) Moonseong Heo et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started